These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 14679275)

  • 41. The U.S. vaccine supply.
    Schwartz HK
    N Engl J Med; 2005 Mar; 352(10):1046-7; author reply 1046-7. PubMed ID: 15762001
    [No Abstract]   [Full Text] [Related]  

  • 42. Public health. U.S. vaccine supply falls seriously short.
    Cohen J
    Science; 2002 Mar; 295(5562):1998-2001. PubMed ID: 11896251
    [No Abstract]   [Full Text] [Related]  

  • 43. Vanishing vaccinations: why are so many Americans opting out of vaccinating their children?
    Calandrillo SP
    Univ Mich J Law Reform; 2004; 37(2):353-440. PubMed ID: 15568260
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tiered use of inactivated influenza vaccine in the event of a vaccine shortage.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2005 Aug; 54(30):749-50. PubMed ID: 16079741
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gaps in vaccine financing for underinsured children in the United States.
    Lee GM; Santoli JM; Hannan C; Messonnier ML; Sabin JE; Rusinak D; Gay C; Lett SM; Lieu TA
    JAMA; 2007 Aug; 298(6):638-43. PubMed ID: 17684186
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Recommended childhood immunization schedule--United States, 2002.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2002 Jan; 51(2):31-3. PubMed ID: 11820528
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Wyeth Pharmaceutical's perspective on vaccine production.
    Stiles GL
    Md Med; 2005; 6(1):22-3. PubMed ID: 15869103
    [No Abstract]   [Full Text] [Related]  

  • 48. Surveillance of Vaccination Coverage Among Adult Populations - United States, 2014.
    Williams WW; Lu PJ; O'Halloran A; Kim DK; Grohskopf LA; Pilishvili T; Skoff TH; Nelson NP; Harpaz R; Markowitz LE; Rodriguez-Lainz A; Bridges CB;
    MMWR Surveill Summ; 2016 Feb; 65(1):1-36. PubMed ID: 26844596
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vaccines in the pipeline: the path from development to use in the United States.
    Pickering LK; Walton LR
    Pediatr Ann; 2013 Aug; 42(8):146-52. PubMed ID: 23910027
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sustaining GAVI-supported vaccine introductions in resource-poor countries.
    Zuber PL; El-Ziq I; Kaddar M; Ottosen AE; Rosenbaum K; Shirey M; Kamara L; Duclos P
    Vaccine; 2011 Apr; 29(17):3149-54. PubMed ID: 21354249
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Are vaccine shortages a relevant public health issue in Europe? Results from a survey conducted in the framework of the EU Joint Action on Vaccination.
    Filia A; Rota MC; Grossi A; Martinelli D; Prato R; Rezza G
    Vaccine; 2022 Mar; 40(13):1987-1995. PubMed ID: 35190211
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Updated recommendations from the Advisory Committee on Immunization Practices in response to delays in supply of influenza vaccine for the 2000-01 season.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2000 Oct; 49(39):888-92. PubMed ID: 11055742
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lessons learned from a review of the development of selected vaccines. National Vaccine Advisory Committee.
    Peter G; des Vignes-Kendrick M; Eickhoff TC; Fine A; Galvin V; Levine MM; Maldonado YA; Marcuse EK; Monath TP; Osborn JE; Plotkin S; Poland GA; Quinlisk MP; Smith DR; Sokol M; Soland DB; Whitley-Williams PN; Williamson DE; Breiman RF
    Pediatrics; 1999 Oct; 104(4 Pt 1):942-50. PubMed ID: 10506239
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Immunisation schedule of the Spanish Association of Paediatrics: 2014 recommendations].
    Moreno-Pérez D; Alvarez García FJ; Arístegui Fernández J; Cilleruelo Ortega MJ; Corretger Rauet JM; García Sánchez N; Hernández Merino A; Hernández-Sampelayo Matos T; Merino Moína M; Ortigosa Del Castillo L; Ruiz-Contreras J;
    An Pediatr (Barc); 2014 Jan; 80(1):55.e1-55.e37. PubMed ID: 24412025
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunizations in the United States: success, structure, and stress.
    Orenstein WA; Douglas RG; Rodewald LE; Hinman AR
    Health Aff (Millwood); 2005; 24(3):599-610. PubMed ID: 15886150
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vaccines and Immunization Practice.
    Hogue MD; Meador AE
    Nurs Clin North Am; 2016 Mar; 51(1):121-36. PubMed ID: 26897429
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Improving the reliability of the U.S. vaccine supply: an evaluation of alternatives.
    Mowery DC; Mitchell V
    J Health Polit Policy Law; 1995; 20(4):973-1000. PubMed ID: 8770760
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Factors affecting U.S. manufacturers' decisions to produce vaccines.
    Coleman MS; Sangrujee N; Zhou F; Chu S
    Health Aff (Millwood); 2005; 24(3):635-42. PubMed ID: 15886154
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The role of manufacturers in the implementation of global traceability standards in the supply chain to combat vaccine counterfeiting and enhance safety monitoring.
    Jarrett S; Wilmansyah T; Bramanti Y; Alitamsar H; Alamsyah D; Krishnamurthy KR; Yang L; Pagliusi S
    Vaccine; 2020 Dec; 38(52):8318-8325. PubMed ID: 33199075
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The U.S. vaccine and immunization enterprise: Working to sustain and foster vaccine innovation.
    Shen AK
    Hum Vaccin; 2009 Oct; 5(10):649-53. PubMed ID: 19713758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.